WallStreetZenWallStreetZen

NASDAQ: FUSN
Fusion Pharmaceuticals Inc Stock Ownership - Who owns Fusion Pharmaceuticals?

Insider buying vs selling

Have Fusion Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when FUSN insiders and whales buy or sell their stock.

FUSN Shareholders

What type of owners hold Fusion Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Federated Hermes Inc12.85%10,886,153$231.88MInstitution
Avidity Partners Management LP7.68%6,500,328$138.46MInstitution
Deerfield Management Company LP Series C7.56%6,401,000$136.34MInstitution
Fmr LLC6.27%5,313,294$113.17MInstitution
Tpg Group Holdings Sbs Advisors Inc5.73%4,853,588$103.38MInsider
Johan Christenson4.50%3,807,247$81.09MInsider
Healthcap Vii LP4.50%3,807,247$81.09MInsider
Johnson Johnson4.33%3,670,516$78.18MInstitution
Johnson Johnson4.33%3,670,516$78.18MInsider
Varian Medical Systems Inc3.80%3,218,632$68.56MInsider

1 of 3

FUSN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FUSN71.20%28.80%
GERN72.04%1.23%Net Buying
MORF64.32%35.68%Net BuyingNet Selling
CPRX71.64%16.33%Net BuyingNet Buying
RCUS48.31%51.69%Net BuyingNet Buying

Fusion Pharmaceuticals Stock Ownership FAQ

Who owns Fusion Pharmaceuticals?

Fusion Pharmaceuticals (NASDAQ: FUSN) is owned by 71.78% institutional shareholders, 29.04% Fusion Pharmaceuticals insiders, and 0.00% retail investors. Tpg Group Holdings Sbs Advisors Inc is the largest individual Fusion Pharmaceuticals shareholder, owning 4.85M shares representing 5.73% of the company. Tpg Group Holdings Sbs Advisors Inc's Fusion Pharmaceuticals shares are currently valued at $103.48M.

If you're new to stock investing, here's how to buy Fusion Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.